Thrivent Financial for Lutherans Raises Stake in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE)

Thrivent Financial for Lutherans grew its position in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) by 23.6% during the 3rd quarter, Holdings Channel reports. The fund owned 32,509 shares of the company’s stock after buying an additional 6,214 shares during the quarter. Thrivent Financial for Lutherans’ holdings in iShares U.S. Pharmaceuticals ETF were worth $2,295,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also made changes to their positions in the company. Allworth Financial LP raised its position in iShares U.S. Pharmaceuticals ETF by 9.4% during the third quarter. Allworth Financial LP now owns 1,853 shares of the company’s stock worth $131,000 after acquiring an additional 159 shares during the last quarter. Assetmark Inc. raised its position in shares of iShares U.S. Pharmaceuticals ETF by 100.0% in the third quarter. Assetmark Inc. now owns 432 shares of the company’s stock valued at $31,000 after buying an additional 216 shares during the last quarter. US Bancorp DE increased its position in iShares U.S. Pharmaceuticals ETF by 137.0% during the third quarter. US Bancorp DE now owns 384 shares of the company’s stock worth $27,000 after purchasing an additional 222 shares during the last quarter. Mercer Global Advisors Inc. ADV increased its position in iShares U.S. Pharmaceuticals ETF by 7.4% during the second quarter. Mercer Global Advisors Inc. ADV now owns 3,837 shares of the company’s stock worth $254,000 after purchasing an additional 266 shares during the last quarter. Finally, Cultivar Capital Inc. acquired a new position in iShares U.S. Pharmaceuticals ETF during the second quarter worth approximately $25,000.

iShares U.S. Pharmaceuticals ETF Stock Performance

Shares of IHE stock opened at $69.24 on Thursday. iShares U.S. Pharmaceuticals ETF has a one year low of $57.96 and a one year high of $72.94. The company has a 50 day moving average price of $69.90 and a 200 day moving average price of $68.82. The firm has a market capitalization of $699.28 million, a price-to-earnings ratio of 6.49 and a beta of 0.58.

iShares U.S. Pharmaceuticals ETF Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.